Bullboard - Stock Discussion Forum Insmed Inc INSM

Healthcare Biotechnology

Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs... see more

Add To Watchlist

NDAQ:INSM - Post Discussion

Insmed Inc > Insmed stock doubles on positive ASPEN study results

View:

Post by whytestocks on May 28, 2024 10:00am

Insmed stock doubles on positive ASPEN study results

News; $INSM Insmed stock doubles on positive ASPEN study results2024-05-28 07:08:55 ET Shares of Insmed Inc (NASDAQ: INSM) more than doubled on Tuesday after the biopharmaceutical firm reported positive results for its ASPEN study. Insmed stock soars on topline results from ASPEN study The Phase 3 trial evaluated “efficacy, safety, an...INSM - Insmed stock doubles on positive ASPEN study results